TradingView’s own chart and price feed. The page’s numbers are end-of-day closes.
Data provided by Databento (end of day). Next close = the first close after a story against the close before it; official daily closes only, not a call, not advice.
The numbers
fiscal 2025, as filed with the SEC · 66-metric EOD snapshot via Databento
Market cap$96M
Enterprise value$102.4M
Revenue$61.9M +10.2%
ROIC-21.2%
EPS, diluted$-0.47 +34.7%
Modern Valuation (EOD)
Market Cap$96M
Enterprise Value$102.4M
EV / True FCF—
EV / FCF—
EV / Gross Profit—
EV / EBIT—
EV / Sales1.65
P / E (GAAP)—
P / FCF—
P / Oper. CF—
P / Book3.00
Owner & Cash Yields
True FCF Yield—
FCF Yield—
Owner Earn. Yield—
Earnings Yield-12.0%
Shareholder Yield—
Buyback Yield—
Dividend Yield—
Dividend / sh—
Payout Ratio—
FCF / sh—
EPS (diluted)$-0.47
Compounder & Returns
Rule of 40—
ROIC-21.2%
Cash ROIC (CROIC)—
GP / Assets—
ROE-35.9%
ROA-12.1%
Gross Margin—
Oper. Margin-13.2%
Net Margin-18.5%
FCF Margin—
True FCF Margin—
Quality & Dilution
Cash Conversion—
Accrual Ratio+1.1%
SBC % of FCF—
SBC % of Rev10.2%
Reinvest. Rate—
Sales Growth Y/Y+10.2%
Sales 3Y CAGR−5.7%
EPS Growth Y/Y+34.7%
FCF Growth Y/Y—
FCF 3Y CAGR—
Share Change Y/Y+19.9%
Balance Sheet & Scale
Revenue (FY)$61.9M
Gross Profit (FY)—
Oper. Income (FY)$-8.2M
GAAP Net Income$-11.4M
True FCF (ex-SBC)—
Cash & Equiv$24.1M
Total Debt$30.9M
Net Cash (Debt)$-6.8M
Net Cash % MCap−7.1%
Debt / FCF (yrs)—
Current Ratio1.79
Price & Technicals (EOD)
Perf Week−16.89%
Perf Month−29.31%
Perf Quarter−50.73%
Perf Half Y−40.19%
Perf YTD−27.93%
SMA 20 Dist−19.83%$4.60
SMA 50 Dist−34.71%$5.65
SMA 100 Dist−41.58%$6.32
Window High−53.70%$7.97
Window Low0.00%$3.69
RSI (14) · Vol28.886%v
Income Distribution & Cash Flow ConversionHow every dollar of DERM revenue flows through cost of goods, operating expenses, taxes, GAAP net income, and dilution-adjusted free cash flow
Unlocked SEC EDGAR Accounting Statements (USD)All 3 statements · Common-size (% of Revenue / Assets) · YoY growth · Tap any core row to explain
Line Item (USD)
FY2021
FY2022
FY2023
FY2024
FY2025
YoY Δ
4Y CAGR
Trend
Income Statement
Revenue ▸
$63.1M
$73.7M
$79.2M
$56.1M
$61.9M
+10.2%
−0.5%
Cost of Revenue (COGS)
$32.1M
$30.8M
$22.9M
$20.9M
$20.9M
+0.2%
−10.1%
Research & Development (R&D)
$2.7M
$10.9M
$7.5M
$9.9M
$480,000
−95.1%
−35.3%
Selling, General & Admin (SG&A)
$39.8M
$59.5M
$43.9M
$40.2M
$44.4M
+10.4%
+2.7%
Operating Income (EBIT) ▸
$-34.9M
$-27.5M
$-2.1M
$-13.7M
$-8.2M
+40.3%
—
Interest Expense
$7.0M
$2.0M
$1.7M
$2.7M
$3.7M
+37.0%
−14.8%
Income Tax Expense
$1.6M
$63,000
$221,000
$61,000
$60,000
−1.6%
−56.2%
GAAP Net Income ▸
$-44.0M
$-29.6M
$-3.9M
$-14.7M
$-11.4M
+22.1%
—
Diluted EPS ▸
$-4.32
$-1.69
$-0.21
$-0.72
$-0.47
+34.7%
—
Diluted Shares
10.2M
17.5M
18.2M
20.4M
24.5M
+19.9%
+24.5%
Balance Sheet
Cash & Equivalents
$49.1M
$32.0M
$27.4M
$20.3M
$24.1M
+18.6%
−16.3%
Inventory
$9.9M
$14.2M
$10.2M
$14.4M
$9.6M
−33.3%
−0.6%
Total Current Assets
$84.5M
$77.7M
$56.5M
$48.2M
$66.9M
+38.8%
−5.7%
Total Assets
$97.3M
$105.2M
$76.8M
$80.2M
$94.6M
+17.9%
−0.7%
Total Current Liabilities
$51.6M
$66.8M
$41.9M
$35.2M
$37.4M
+6.4%
−7.7%
Total Debt (Short + Long Term)
$33.1M
$35.3M
$24.6M
$34.8M
$30.9M
−11.3%
−1.7%
Total Liabilities
$55.2M
$88.2M
$56.5M
$60.2M
$62.7M
+4.3%
+3.2%
Stockholders' Equity
$42.0M
$17.0M
$20.4M
$20.1M
$31.9M
+58.7%
−6.7%
Net Cash / (Net Debt)
$16.0M
$-3.3M
$2.9M
$-14.5M
$-6.8M
+53.1%
—
Invested Capital
$26.0M
$20.2M
$17.5M
$34.6M
$38.7M
+11.8%
+10.4%
Cash Flow & Capital Allocation
Operating Cash Flow (OCF) ▸
$-2.2M
$-13.5M
$5.2M
$-9.1M
$-12.4M
−36.3%
—
Depreciation & Amortization (D&A)
$0
—
—
—
$0
—
—
Stock-Based Compensation (SBC)
$2.5M
$4.4M
$2.6M
$6.1M
$6.3M
+3.1%
+26.4%
Fundamentals, income distribution and multi-year statements from SEC EDGAR filings (public domain). Valuation multiples, performance and technicals computed from Databento 1D EOD closes. For information only, not investment advice.
On the Wire
what DERM did at the next close after each story
No Wire story has named DERM yet.
The Wire at 7 AM ET, free. Top stories with a bull and a bear case on each, every morning. No account needed.
What happened · big days
19 big days in a year, and what we hold on each
A big day is a close more than 6.54% from the one before, three times DERM’s median day (2.18%). On 0 of the 19, its peer group moved the same way at least half as far. We show what we hold. We never name a cause.
every other trading daya big day, numbered in the list below±6.54%Hover a bar for its day. Click a big day to open it.
Shaded: since our stories began, Jun 10. Tap a bar for its day.
#DayDERMWhat we hold that dayGroup (median of 4) · each
1 Jan 15, 2026+6.63%
Before our storiesgroup −1.2%, did not move with it
1Jan 15, 2026+6.63%
Before our stories
−1.2% did not move with itJNJ +0.5 · MRK −0.0 · ABBV −2.3 · LLY −3.8
2 Jan 20, 2026+8.99%
Before our storiesgroup +0.1%, did not move with it
2Jan 20, 2026+8.99%
Before our stories
+0.1% did not move with itMRK +0.6 · LLY +0.3 · ABBV −0.1 · JNJ −0.2
3 Mar 13, 2026−6.96%
Before our storiesgroup −0.2%, did not move with it
3Mar 13, 2026−6.96%
Before our stories
−0.2% did not move with itABBV −2.5 · MRK −0.3 · JNJ −0.2 · LLY +0.8
4 Mar 26, 2026−30.01%
Resultsgroup −0.3%, did not move with it
4Mar 26, 2026−30.01%
ResultsFirst close after the Mar 25 results filing
−0.3% did not move with itLLY −2.1 · MRK −0.4 · JNJ −0.3 · ABBV +1.9
5 Mar 31, 2026+6.83%
Before our storiesgroup +1.9%, did not move with it
5Mar 31, 2026+6.83%
Before our stories
+1.9% did not move with itLLY +3.7 · ABBV +2.0 · MRK +1.9 · JNJ +0.8
6 Apr 2, 2026+6.68%
Before our storiesgroup −1.2%, did not move with it
6Apr 2, 2026+6.68%
Before our stories
−1.2% did not move with itMRK +0.0 · JNJ −0.4 · LLY −2.0 · ABBV −2.9
7 Apr 8, 2026+7.68%
Before our storiesgroup +2.5%, did not move with it
7Apr 8, 2026+7.68%
Before our stories
+2.5% did not move with itMRK +3.3 · ABBV +2.5 · LLY +2.4 · JNJ +1.2
8 May 14, 2026+22.35%
Resultsgroup +0.1%, did not move with it
8May 14, 2026+22.35%
ResultsFirst close after the May 13 results filing
+0.1% did not move with itABBV +1.1 · JNJ +0.2 · MRK −0.0 · LLY −0.9
9 Jun 25, 2026−9.20%
Nothing on DERMgroup +2.6%, did not move with it
9Jun 25, 2026−9.20%
Nothing on DERMNo DERM story, brief or results filing in our record that day
+2.6% did not move with itLLY +0.9 · JNJ +1.6 · ABBV +3.5 · MRK +4.0
10 Jul 7, 2026−6.58%
Nothing on DERMgroup +2.3%, did not move with it
10Jul 7, 2026−6.58%
Nothing on DERMNo DERM story, brief or results filing in our record that day
+2.3% did not move with itABBV −0.0 · MRK +1.6 · LLY +3.0 · JNJ +3.0
11 Jul 23, 2026−7.58%
Nothing on DERMgroup +1.7%, did not move with it
11Jul 23, 2026−7.58%
Nothing on DERMNo DERM story, brief or results filing in our record that day
+1.7% did not move with itJNJ +1.4 · ABBV +1.4 · LLY +2.0 · MRK +2.4
12 Aug 20, 2026+9.99%
Nothing on DERMgroup −2.2%, did not move with it
12Aug 20, 2026+9.99%
Nothing on DERMNo DERM story, brief or results filing in our record that day
−2.2% did not move with itABBV −1.6 · MRK −2.1 · JNJ −2.2 · LLY −2.8
13 Sep 23, 2026−10.34%
Nothing on DERMgroup −0.8%, did not move with it
13Sep 23, 2026−10.34%
Nothing on DERMNo DERM story, brief or results filing in our record that day
−0.8% did not move with itMRK −1.9 · LLY −1.6 · ABBV −0.1 · JNJ −0.0
14 Oct 6, 2026−7.92%
Nothing on DERMgroup +1.0%, did not move with it
14Oct 6, 2026−7.92%
Nothing on DERMNo DERM story, brief or results filing in our record that day
+1.0% did not move with itABBV +0.3 · JNJ +0.7 · LLY +1.3 · MRK +1.7
15 Oct 14, 2026−7.04%
Nothing on DERMgroup +3.5%, did not move with it
15Oct 14, 2026−7.04%
Nothing on DERMNo DERM story, brief or results filing in our record that day
+3.5% did not move with itJNJ +2.1 · ABBV +3.3 · LLY +3.6 · MRK +3.8
16 Oct 21, 2026−8.05%
Nothing on DERMgroup −0.8%, did not move with it
16Oct 21, 2026−8.05%
Nothing on DERMNo DERM story, brief or results filing in our record that day
−0.8% did not move with itABBV −1.5 · LLY −1.0 · JNJ −0.6 · MRK +1.1
17 Nov 2, 2026−7.35%
Nothing on DERMgroup −0.9%, did not move with it
17Nov 2, 2026−7.35%
Nothing on DERMNo DERM story, brief or results filing in our record that day
−0.9% did not move with itABBV −2.0 · JNJ −1.0 · MRK −0.8 · LLY −0.5
18 Nov 5, 2026−9.09%
Nothing on DERMgroup −2.3%, did not move with it
18Nov 5, 2026−9.09%
Nothing on DERMNo DERM story, brief or results filing in our record that day
−2.3% did not move with itLLY −3.8 · MRK −2.3 · ABBV −2.2 · JNJ −1.4
19 Nov 16, 2026−14.55%
Nothing on DERMgroup −1.0%, did not move with it
19Nov 16, 2026−14.55%
Nothing on DERMNo DERM story, brief or results filing in our record that day
−1.0% did not move with itMRK −2.2 · JNJ −1.1 · LLY −0.8 · ABBV −0.2
A story on the same day is not a cause, and a group move is not proof either. Group: the median of LLY, JNJ, ABBV and MRK that day, the largest companies in DERM’s SEC industry; “moved with DERM” means the same direction and at least half the size.
What’s next · results
Before the next report: what the first day after the last four did
Six trading days after each results filing (SEC 8-K, Item 2.02). DERM reports after the close, so day 1 is the next close. Each time, day 6 ended on the same side as day 1.
Reported Nov 12, 2025
day 1−15.31%day 6−16.96%
Reported Mar 25, 2026
day 1−30.01%day 6−27.53%
Reported May 13, 2026
day 1+22.35%day 6+19.65%
Reported Aug 12, 2026
day 1+3.42%day 6+16.49%
Next report: expected mid FebruaryEstimated from the dates of its last four results filings. Not announced. Since the Nov 12 report: −11.16%. Four reports is a small sample.
Each line is DERM’s close against its close before the filing, on licensed end-of-day closes. What happened after each report, not a forecast; a move on the day is not a cause.
Same industry
DERM against four drug peers, a year at 100
DERM is down 47.7% in a year. Merck is up 46.7%, Johnson & Johnson 36.7%, Eli Lilly 33.6% and AbbVie 23.9%. All four did more. Weekly closes, Nov 21, 2025 = 100, on a log scale, so the same percentage move is the same height on every line.
End-of-day closes (Databento EOD), the last close of each week. The four peers are the largest US-listed companies by market value in DERM’s SEC industry (Pharmaceutical Preparations) with a year of closes. It shows what the closes did; a move here is not a cause, a forecast or a call.